CHB FAQ
6 questionsWhat does Global X China Biotech Innovation ETF do?
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index ("underlying index"). The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in...Where does CHB stock trade?
Global X China Biotech Innovation ETF (CHB) is listed on NASDAQ.What sector and industry is CHB in?
Global X China Biotech Innovation ETF operates in the n/a sector.When did Global X China Biotech Innovation ETF go public?
Global X China Biotech Innovation ETF (CHB) completed its IPO in n/a.What companies are similar to CHB?
Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare CHB side-by-side with any of them on Quantisnow.How can I track CHB on Quantisnow?
Quantisnow aggregates Global X China Biotech Innovation ETF's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CHB to receive live email and push alerts on every new disclosure.